In addition, among adults with immune thrombocytopenia, thrombotic complications appear to be slightly more frequent in those receiving TPO-RAs.77 Accordingly, concerns remain regarding the potential of TPO-RAs to increase thrombosis in patients with cancer. Here, TPO is linked to cancer.